Aortic & peripheral vascular disease

Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease

J Am Coll CardiolPublished Randomised controlled trial

Primary result · Percent change in LDL-CResult — go to the resultLeast-squares mean difference −43.7 % 95% CI −57.6% to −29.9%

Authors' conclusion

OPTIMIZE PAD-1 showed that an interprofessional, algorithm-based program can achieve rapid LDL-C lowering in vascular patients using available insurance and therapies, and LDL-C targets can be met in most patients if enabled by optimized systems of care.

Study context

Population
Patients with peripheral artery disease (PAD) and low-density lipoprotein cholesterol (LDL-C) ≥70 mg/dLrandomized
Participants
114 patients
Comparison
Vascular care team vs usual care plus provider education
Primary endpoint
Percent change in LDL-C
Follow-up
12 months
Methodological detailsimplementation trial
  • Implementation trial

Primary result

As reported in the abstract

Least-squares mean difference

−43.7 %

95% CI −57.6% to −29.9%

P < 0.0001

Change by group

Vascular care team

−49.1

mean change · 95% CI −58.7%–-39.5% · %

Usual care

−5.4

mean change · 95% CI −15.3%–4.6% · %

Vascular care team vs Usual care
least-squares mean difference −43.7 % (95% CI −57.6% to −29.9%); P < 0.0001

Further findings

Mean LDL-C in vascular care team (baseline, week 4, month 12)
100.6 mg/dL · Baseline · Week 4 54.8 mg/dL · Month 12 50.1 mg/dL

Achievement of LDL-C <70 mg/dL and <55 mg/dL · 12 months

Vascular care team 8 times as likely to achieve LDL-C <55 mg/dL vs usual care
P < 0.0001
Vascular care team >3 times as likely to achieve LDL-C <70 mg/dL vs usual care

Original publication

Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease. J Am Coll Cardiol. Published 25 June 2024. doi:10.1016/j.jacc.2024.04.034

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.